| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Molecular Biology, National Institute of Neurological and Communicative Disorders and Stroke, NIH, Bethesda, Maryland 20892
Expression of glial fibrillary acidic protein (GFAP) was assayed in 11 glioma-derived cell cultures. Treatment of cells with an inhibitor of guanine nucleotide biosynthesis, mycophenolic acid, enhanced detection of GFAP by indirect immunofluorescence microscopy. Quantitation of GFAP and vimentin demonstrated that enhanced fluorescence occurs without an increase in the level of intermediate filament proteins. Immunoblots provided the most sensitive method for monitoring GFAP expression and showed the limitations of using immunofluorescence detection methods. GFAP was detectable in cultures derived from malignant Grade IV astrocytomas and its expression was stable during the course of the study.
While mycophenolic acid has been reported to induce differentiation in leukemia cells at low concentration (D. L. Lucas et al., J. Clin. Invest., 72: 18891990, 1983), its effect on glioma cultures at concentrations of 100 µM was consistent with a role as an inhibitor of DNA synthesis, and as an effector of altered intermediate filament organization.
1 To whom requests for reprints should be addressed, at Laboratory of Molecular Biology, Building 36, Room 3D-02, NIH, Bethesda, MD 20892.
Received 12/ 3/86. Revised 3/23/87. Revised 5/26/87. Accepted 6/11/87.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |